CoChat
Sign Up
Cited by 332Viral Infections and Immunology ResearchCardiac Fibrosis and RemodelingOcular Diseases and Behçet’s Syndrome

From Infection to Autoimmunity

Fairweather, Delisa, Kaya, Ziya, Shellam, Geoffrey R, Lawson, Cassandra M, Rose, Noel R·2001·Journal of Autoimmunity
DOI 10.1006/jaut.2000.0492
Open this paper in CoChat — free account

Abstract

We have investigated two models of virally-induced autoimmune myocarditis in mice using widely different infectious agents. Infection of susceptible BALB/c mice with either Coxsackievirus or murine cytomegalovirus results in the development of acute myocarditis from day 7-14 after infection, and chronic myocarditis from day 28 onwards. The chronic phase of myocarditis is associated with mononuclear infiltration of the myocardium and the production of autoantibodies to cardiac myosin, although infectious virus cannot be detected past day 14 of infection. T cells and autoantibodies have been shown to be important for the development of autoimmune myocarditis. Many researchers have investigated the role of molecular mimicry in the development of myocarditis after viral infection. This review explores the 'adjuvant' effect of infection on the innate immune response and how this determines the progression to autoimmune disease. We show that NK cells protect against the development of disease, while complement and complement receptors are involved in the development of autoimmune myocarditis induced by inoculation with virus or cardiac myosin, respectively. Our results suggest that the innate immune response to viral and self-antigens may determine whether susceptible strains of mice progress to chronic autoimmune disease. These findings have broad implications for understanding the role of infection in inducing autoimmune disease.

Integrity signals

Registry

Crossref · 10.1006/jaut.2000.0492

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both the mRNA against the SARS-CoV-2 spike protein and the lipid nanoparticle vehicle could provide the adjuvant effect needed to promote myocarditis following vaccination with an mRNA vaccine.

    “Possibly both the mRNA against the SARS-CoV-2 spike protein and the lipid nanoparticle vehicle could provide the adjuvant effect needed to promote myocarditis following vaccination with an mRNA vaccine. 35,51,198”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [35]

  • This time course is the same as observed with the autoimmune CVB3 and murine cytomegalovirus models of myocarditis and EAM.

    “This time course is the same as is observed with the autoimmune CVB3 and murine cytomegalovirus models of myocarditis and EAM (Table S1). 35,124,170,188”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [35]

Cites

Flagged first, then by citations

6 of the 109 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Fairweather, D., Kaya, Z., Shellam, G. R., Lawson, C. M., & Rose, N. R.
Affiliations
  • Johns Hopkins University (US)
  • The University of Western Australia (AU)
  • Murdoch University (AU)
ORCID
Venue
Journal of Autoimmunity
Publisher
Elsevier BV
Published
2001-05
Volume
16
Issue
3
Pages
175-186
ISSN
0896-8411 (ISSN-L)
DOI
10.1006/jaut.2000.0492
OpenAlex
W2076160664
Cited by
328
References
109
Citations by year
2026: 8 · 2025: 7 · 2024: 15 · 2023: 11 · 2022: 10 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 14 · 2015: 14 · 2014: 10 · 2013: 12 · 2012: 15
FWCI
14.45
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Autoimmunity (publishedVersion)
  • PubMed (publishedVersion)
  • Murdoch University Research Portal (submittedVersion)
Funders
  • Deutsche Herzstiftung
  • National Institutes of Health
  • National Health and Medical Research Council
  • National Medical Research Council
  • National Heart, Lung, and Blood Institute (HL-33878, R01HL033878)
  • National Institute of Environmental Health Sciences (ES99003)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
Coxsackie virus, murine cytomegalovirus, molecular mimicry, innate immune response, natural killer cells, complement system, complement receptors, mononuclear cell infiltration, T cells, autoimmunity, BALB/c mice
MeSH terms
Animals, Autoimmune Diseases, Complement System Proteins, Coxsackievirus Infections, Herpesviridae Infections, Humans, Immunity, Active, Immunity, Innate, Killer Cells, Natural, Myocarditis, Autoimmunity, Cytokines, Muromegalovirus, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review